Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds

Recent guidelines will lead to more aggressive treatment of rheumatoid arthritis (RA) to suppress symptoms and slow joint damage.

Continue to recommend methotrexate first as the "anchor" drug.

If this isn't enough, suggest adding one or two other traditional disease-modifying antirheumatic drugs (DMARDs) such as sulfasalazine or hydroxychloroquine...or adding a biologic DMARD (Enbrel, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote